Cargando…
Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about futur...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150973/ https://www.ncbi.nlm.nih.gov/pubmed/32150899 http://dx.doi.org/10.3390/pharmaceutics12030229 |
_version_ | 1783521142231793664 |
---|---|
author | Rautamo, Maria Kvarnström, Kirsi Sivén, Mia Airaksinen, Marja Lahdenne, Pekka Sandler, Niklas |
author_facet | Rautamo, Maria Kvarnström, Kirsi Sivén, Mia Airaksinen, Marja Lahdenne, Pekka Sandler, Niklas |
author_sort | Rautamo, Maria |
collection | PubMed |
description | The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products. |
format | Online Article Text |
id | pubmed-7150973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71509732020-04-20 Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals Rautamo, Maria Kvarnström, Kirsi Sivén, Mia Airaksinen, Marja Lahdenne, Pekka Sandler, Niklas Pharmaceutics Article The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products. MDPI 2020-03-05 /pmc/articles/PMC7150973/ /pubmed/32150899 http://dx.doi.org/10.3390/pharmaceutics12030229 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rautamo, Maria Kvarnström, Kirsi Sivén, Mia Airaksinen, Marja Lahdenne, Pekka Sandler, Niklas Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title | Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title_full | Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title_fullStr | Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title_full_unstemmed | Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title_short | Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals |
title_sort | benefits and prerequisites associated with the adoption of oral 3d-printed medicines for pediatric patients: a focus group study among healthcare professionals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150973/ https://www.ncbi.nlm.nih.gov/pubmed/32150899 http://dx.doi.org/10.3390/pharmaceutics12030229 |
work_keys_str_mv | AT rautamomaria benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals AT kvarnstromkirsi benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals AT sivenmia benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals AT airaksinenmarja benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals AT lahdennepekka benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals AT sandlerniklas benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals |